(Image: Getty/CIPhotos)

Evotec licenses Ncardia’s disease modeling patents

By Melissa Fassbender

Ncardia has entered into a non-exclusive licensing agreement with Evotec through which the drug discovery solutions company will gain access to Ncardia’s stem cell derived cellular disease modeling IP.

Codexis denies Dyadic breach

Codexis Denies Expression System Licence Breach

By Gareth Macdonald

Codexis has denied breaching its licensing deal with Dyadic International and says losing rights to the C1 fungal expression system would hit its CodeXyme business hard.


Follow us


View more


Featured Suppliers

All suppliers